TCGA Cohort (531) | CPTAC Cohort (98) | |
---|---|---|
Age(years) | ||
≥65 | 198(37.3%) | 41(41.8%) |
<65 | 333(62.7%) | 57(58.2%) |
Sex | ||
Male | 345(65.0%) | 75(76.5%) |
Female | 186(35.0%) | 23(23.5%) |
Grade | ||
G1 | 13(2.4%) | 6(6.1%) |
G2 | 229(43.1%) | 47(48.0%) |
G3 | 205(38.6%) | 36(36.7%) |
G4 | 76(14.3%) | 9(9.2%) |
Unknown | 8(1.5%) | 0 |
Stage | ||
I | 266(50.1%) | 46(46.9%) |
II | 57(10.7%) | 11(11.2%) |
III | 124(23.4%) | 31(31.6%) |
IV | 84(15.8%) | 10(10.2%) |
T stage | ||
T1 | 271(51.0%) | 48(49.0%) |
T2 | 69(13.0%) | 12(12.2%) |
T3 | 180(33.9%) | 37(37.8%) |
T4 | 11(2.1%) | 1(1.0%) |
N stage | ||
N1 | 16(3.0%) | / |
N0 | 240(45.2%) | / |
Unknown | 275(51.8%) | / |
M stage | ||
M1 | 79(14.9%) | / |
M0 | 422(79.5%) | / |
Unknown | 30(5.6%) | / |
Survival | ||
Dead | 175(33.0%) | 12(12.2%) |
Living | 356(67.0%) | 86(87.8%) |